Implementation of Kidney Cancer-Specific Training for Clinical Research Nurses
Abstract
Clinical trial development has been critical for improving the outcomes of patients with kidney cancer, with the approval of 13 new treatments in the last 15 years. With proper oversight, clinical trials provide patients safe, early access to new medications that are promising. However, access to these novel treatments can be limited by the availability of expertise. Clinical research nurses (CRNs) are critical members of the patients medical team that ensure that new medications can be delivered ethically, safely, and effectively. We hypothesize that having CRNs that are specialized in kidney cancer will improve the safety and tolerability of patients treated on clinical trials by improving the management of side effects and making sure patients adhere to the schedule and rules of the clinical trial.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2022
- Accession Number
- AD1194700
Entities
People
- Robert Motzer
Organizations
- Memorial Sloan Kettering Cancer Center